Cyteir Therapeutics CEO and leadership

Biotech entrepreneur experienced in building small and large organizations, recruiting and inspiring teams, managing large global organizations, and raising money. Experienced in business development, corporate partnerships, acquisitions and mergers, and corporate governance. Board certified medical oncologist with 25 years’ experience in cancer research from basic laboratory research to drug approval. I have been in the pharmaceutical industry in clinical R&D, project leadership, business development and medical affairs for more than 20 years, with successful global registrations in breast cancer, non-small cell lung cancer and pancreatic cancer. Grew Abraxane to $1B product. Responsibility included drug launches and post-marketing medical strategy for Celgene's hematology/oncology pipeline, including Revlimid, Pomalyst/Imnovid and Abraxane. Led Cyteir from discovery company to clinical stage company.

Long track record in Biotechnology from multiple vantage points in small and large, public and private companies. Roles/experience include Strategy, Portfolio Management, In and Out-Licensing, Corporate Venture Capital, M&A, Investor and Public Relations, Operations, Finance & Accounting, SEC Reporting, Public and Private financing, Manufacturing, General Management, Board positions and Board Committee management. I have a passion for new science and applications to tragic diseases.

Senior-level scientific leader with extensive oncology drug discovery experience at both big pharma and biotech companies. Cellular and molecular pharmacologist by training with experience managing all phases of pre-clinical drug discovery from target validation and library screening through IND submission and clinical biomarker development.Significant start-up company experience with facilities design and build-out, personnel recruitment, and scientific strategy development and implementation.Proven ability to promote cross-functional teamwork, enthusiasm, and loyalty with an organization. Particularly skilled at building and maintaining strong relationships with collaborators through mutual trust and a common-goal focus.Personal interests revolve around enjoying time with his family and keeping physically fit. He enjoys coaching his children's teams and playing a variety of competitive sports himself, including football, basketball, golf, and softball.Specialties: Managing drug discovery, leading scientific collaborations, promoting group enthusiasm and productivity, nurturing his children, and enjoying life.

Biotech entrepreneur experienced in building small and large organizations, recruiting and inspiring teams, managing large global organizations, and raising money. Experienced in business development, corporate partnerships, acquisitions and mergers, and corporate governance. Board certified medical oncologist with 25 years’ experience in cancer research from basic laboratory research to drug approval. I have been in the pharmaceutical industry in clinical R&D, project leadership, business development and medical affairs for more than 20 years, with successful global registrations in breast cancer, non-small cell lung cancer and pancreatic cancer. Grew Abraxane to $1B product. Responsibility included drug launches and post-marketing medical strategy for Celgene's hematology/oncology pipeline, including Revlimid, Pomalyst/Imnovid and Abraxane. Led Cyteir from discovery company to clinical stage company.